Skip to Main Content

Author Details

Joshy George
Peter MacCallum Cancer Centre
2005
85
47
PMIDPaper TitleJournal TitlePublished Year
36287571A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary.J Pathol2023
36287571A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary.J Pathol2023
36445177Adaptive Sentinel Testing in Workplace for COVID-19 Pandemic.J Comput Biol2023
36445177Adaptive Sentinel Testing in Workplace for COVID-19 Pandemic.J Comput Biol2023
33086305Comprehensive Molecular Characterization of Adenocarcinoma of the Gastroesophageal Junction Between Esophageal and Gastric Adenocarcinomas.Ann Surg2022
353815253D patient-derived tumor models to recapitulate pediatric brain tumors In Vitro.Transl Oncol2022
36149794Multiplex immunofluorescence-guided laser capture microdissection for spatial transcriptomics of metastatic melanoma tissues.STAR Protoc2022
36069866A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non-Small Cell Lung Cancer.Cancer Res2022
36688010Cancer stem cells, not bulk tumor cells, determine mechanisms of resistance to SMO inhibitors.Cancer Res Commun2022
33086305Comprehensive Molecular Characterization of Adenocarcinoma of the Gastroesophageal Junction Between Esophageal and Gastric Adenocarcinomas.Ann Surg2022
35140215Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target.Nat Commun2022
353815253D patient-derived tumor models to recapitulate pediatric brain tumors In Vitro.Transl Oncol2022
36688010Cancer stem cells, not bulk tumor cells, determine mechanisms of resistance to SMO inhibitors.Cancer Res Commun2022
36149794Multiplex immunofluorescence-guided laser capture microdissection for spatial transcriptomics of metastatic melanoma tissues.STAR Protoc2022
36069866A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non-Small Cell Lung Cancer.Cancer Res2022
35140215Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target.Nat Commun2022
33277667SFRP4 drives invasion in gastric cancer and is an early predictor of recurrence.Gastric Cancer2021
33857287Human KIT+ myeloid cells facilitate visceral metastasis by melanoma.J Exp Med2021
33806030Classification of Molecular Subtypes of High-Grade Serous Ovarian Cancer by MALDI-Imaging.Cancers (Basel)2021
33277667SFRP4 drives invasion in gastric cancer and is an early predictor of recurrence.Gastric Cancer2021
34385332Local versus systemic control of bone and skeletal muscle mass by components of the transforming growth factor-β signaling pathway.Proc Natl Acad Sci U S A2021
33806030Classification of Molecular Subtypes of High-Grade Serous Ovarian Cancer by MALDI-Imaging.Cancers (Basel)2021
33857287Human KIT+ myeloid cells facilitate visceral metastasis by melanoma.J Exp Med2021
34385332Local versus systemic control of bone and skeletal muscle mass by components of the transforming growth factor-β signaling pathway.Proc Natl Acad Sci U S A2021
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
32277480ABCC4/MRP4 contributes to the aggressiveness of Myc-associated epithelial ovarian cancer.Int J Cancer2020
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
33039710CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.EBioMedicine2020
33176162Poison Exon Splicing Regulates a Coordinated Network of SR Protein Expression during Differentiation and Tumorigenesis.Mol Cell2020
32900939Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight.Proc Natl Acad Sci U S A2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
33176162Poison Exon Splicing Regulates a Coordinated Network of SR Protein Expression during Differentiation and Tumorigenesis.Mol Cell2020
33039710CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.EBioMedicine2020
32900939Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight.Proc Natl Acad Sci U S A2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
32277480ABCC4/MRP4 contributes to the aggressiveness of Myc-associated epithelial ovarian cancer.Int J Cancer2020
30719612Health risks from PAHs and potentially toxic elements in street dust of a coal mining area in India.Environ Geochem Health2019
31775037Differential Functions of Splicing Factors in Mammary Transformation and Breast Cancer Metastasis.Cell Rep2019
31167661A computational method to aid the design and analysis of single cell RNA-seq experiments for cell type identification.BMC Bioinformatics2019
31262303Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines.BMC Med Genomics2019
30719612Health risks from PAHs and potentially toxic elements in street dust of a coal mining area in India.Environ Geochem Health2019
31775037Differential Functions of Splicing Factors in Mammary Transformation and Breast Cancer Metastasis.Cell Rep2019
31262303Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines.BMC Med Genomics2019
31167661A computational method to aid the design and analysis of single cell RNA-seq experiments for cell type identification.BMC Bioinformatics2019
29061645Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer.Clin Cancer Res2018
30012670IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer.Cancer Res2018
30560892High-resolution deconstruction of evolution induced by chemotherapy treatments in breast cancer xenografts.Sci Rep2018
29477918Tracing source, distribution and health risk of potentially harmful elements (PHEs) in street dust of Durgapur, India.Ecotoxicol Environ Saf2018
29061645Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer.Clin Cancer Res2018
30012670IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer.Cancer Res2018
  • 1 - 50 of 170

Recommended Authors

Andrew Goodspeed
University of Colorado Denver | Anschutz Medical Campus
Career Start Year 2013
Number of shared co-authors 1
Yari Ciani
University of Trento
Career Start Year 2012
Number of shared co-authors 1
Yuexin Liu
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 9
Darragh G McArt
Queen's University Belfast
Career Start Year 2009
Number of shared co-authors 1
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 4
Qiyuan Li
National Institute of Data Science in Health and Medicine, Xiamen University
Career Start Year 2008
Number of shared co-authors 53
Sander R van Hooff
Princess Maxima Center for Pediatric Oncology
Career Start Year 2008
Number of shared co-authors 0
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 8
Ritu Roy
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 0
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 5
Pichai Raman
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2006
Number of shared co-authors 4
Markus Riester
Novartis Institutes for BioMedical Research
Career Start Year 2005
Number of shared co-authors 7
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 12
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 5
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 13
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 18
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 10
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Habib Hamidi
Genentech Inc.
Career Start Year 2002
Number of shared co-authors 15
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 3
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 37
Luciano G Martelotto
Monash University
Career Start Year 2000
Number of shared co-authors 6
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 51
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 5
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 4
Aedin C Culhane
Dana-Farber Cancer Institute & Harvard School of Public Health
Career Start Year 1996
Number of shared co-authors 12
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 3
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 61
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 7
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 8

Collaborators

David D L Bowtell
Peter MacCallum Cancer Centre
Co-authored papers 35
Anna DeFazio
Westmead Hospital
Co-authored papers 22
Dariush Etemadmoghadam
Peter MacCallum Cancer Centre
Co-authored papers 17
Sian Fereday
Peter MacCallum Cancer Centre
Co-authored papers 15
Michael S Anglesio
University of British Columbia
Co-authored papers 11
Paul Harnett
Westmead Clinical School, University of Sydney
Co-authored papers 10
Catherine J Kennedy
The Westmead Institute for Medical Research, University of Sydney
Co-authored papers 9
Yoke-Eng Chiew
Westmead Hospital
Co-authored papers 8
Kathryn Alsop
Peter MacCallum Cancer Centre
Co-authored papers 8
Nadia Traficante
Peter MacCallum Cancer Centre
Co-authored papers 8
Joy Hendley
Peter MacCallum Cancer Centre
Co-authored papers 7
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 7
Martin K??bel
University of Calgary
Co-authored papers 7
David G Huntsman
University of British Columbia
Co-authored papers 7
Edison T Liu
USA The Jackson Laboratory Cancer Center
Co-authored papers 7
Raghwa Sharma
Westmead Hospital
Co-authored papers 6
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 6
Gordon K Smyth
The University of Melbourne
Co-authored papers 5
Michael J Birrer
Co-authored papers 5
James D Brenton
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 5
Kylie L Gorringe
Co-authored papers 5
Aleksandra Gentry-Maharaj
UCL EGA Institute for Women's Health, University College London
Co-authored papers 5
Vladimir A Kuznetsov
Co-authored papers 5
Bo Gao
Crown Princess Mary Cancer Centre, Westmead Hospital
Co-authored papers 5
Usha Menon
College of Nursing, University of South Florida
Co-authored papers 5
Huei San Leong
Peter MacCallum Cancer Centre
Co-authored papers 5
Nicola Waddell
QIMR Berghofer Medical Research Institute
Co-authored papers 5
Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers 5
George Au-Yeung
The University of Melbourne
Co-authored papers 5
Michelle J Henderson
Children's Cancer Institute, Lowy Cancer Research Centre
Co-authored papers 5
Release 1.2